PneumoWave today announced the closing of £7.5 m Series A financing which will enable clinical validation and regulatory submission of its biosensor technology platform January
Today is Opioid Awareness Day August 30, 2022 Today is Opioid Awareness Day. Our Chief Executive Officer and Founder Dr Bruce Henderson has written a
PneumoWave Featured in the Scotsman June 20, 2022 We are delighted to be featured in the Scotsman newspaper: Digital health firm PneumoWave aiming to double
Dr Gary Cooney appointed as Mental Health Lead April 20, 2022 Digital health company PneumoWave today announced the appointment of Dr Gary Cooney as Mental
Dundee University start RESCU trial of PneumoWave’s wearable biosensor device aiming to cut opioid overdose deaths March 1, 2022 Glasgow, February 28, 2022, Healthtech company
PneumoWave & King’s College London Collaborate in Clinical Trial January 19, 2022 Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the use
PneumoWave and NHS Greater Glasgow & Clyde Announce Clinical Trial Aiming to Reduce Deaths from Respiratory Depression November 2, 2021 Digital therapeutics company PneumoWave (formerly
Rebrand of Altair Medical to PneumoWave October 13, 2021 UK based Altair Medical today announced, as part of its ongoing growth story, that it is
Altair Medical secures $3.1m in Pre-Series A financing April 16, 2021 UK based Altair Medical today announced it has secured £2.25m ($3.1m) of Pre-Series A
Storm ID, Altair Medical & NHS GGC develop a respiratory monitoring service for COVID-19 patients in new clinical trial Feburary 9, 2021 Scottish digital transformation